|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Worldwide Market for Biotherapeutics, 2000-2005 |
|
|
|
|
€ 80,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
1 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
DNA Computing-Tool for High-Performance Simulation
20 pages | Juillet 2002 |
The disciple of "DNA Computing" involves in cross-disciplinary research process between molecular and cellular biology involves the computational process in developing formal models of biological phen |
350,00 €
|
| |
| |
Outsourcing in the Biotech Indsutry
20 pages | Juillet 2002 |
Outsourcing is revolutionising the biotech industry.
Companies have realised that with outsourcing, they can utilise their synergies and work together to deliver products at a faster rate.
The e |
400,00 €
|
| |
| |
Lead Validation Platforms IRCD
pages | Juillet 2001 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development.
The issue is not how many new compounds can one make per day, but rather how many c |
1 200,00 €
|
| |
| |
Biotech Industry Potential: Emerging Markets & Trends
15 pages | Novembre 2002 |
The global biotech industry is comprised of 4,284 companies in 25 nations.
The 622 public companies generated revenues of $35 billion, spent $16 billion in R&D and employed more than 188,000 people |
250,00 €
|
| |
| |
Functional Proteomics and Emerging Bio-IT market
pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
Human Genome: Its future
20 pages | Avril 2003 |
Genetic testing interests the companies and the government alike.
Companies are racing to understand and tap the mass of information pouring out of the Human Genome Project.
It is raising hopes |
400,00 €
|
| |
| |
04-021: The U.S. Market for Synthetic Oligonucleotides: Establishing Differentiation for Success
183 pages | Avril 2004 |
This report provides a synopsis of both the DNA and RNA oligo market.
It highlights the current and future research trends driving demand, as well as throughput levels, preferred formats, specialty |
1 200,00 €
|
| |
| |
04-012: How Life Scientists Buy Products: Implications for Effective Channel Management
303 pages | Mars 2004 |
This report is designed to help suppliers understand how researchers place orders and what drives them to use one method over another |
880,00 €
|
| |
| |
The Biotechnology Industry in US & Europe
22 pages | Mai 2002 |
A new report by RocSearch, The Biotechnology Industry in US & Europe, gives an overview of the global biotechnology industry.
It emphasizes current and emerging technologies including monoclonal an |
500,00 €
|
| |
| |
Pharmacogenomics IRCD
pages | Juillet 2001 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which are |
1 200,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Worldwide Market for Biotherapeutics, 2000-2005 |
|
|
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
|
|
PPLSEN
|
|
|
|
|
